Trial reportScientific reports2025
Short-term outcomes comparison of KangDuo 2.0 and Da Vinci Xi in radical cystectomy.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Comparative outcomes of KangDuo and da Vinci robot-assisted ureteral reimplantation: a retrospective cohort study.Translational andrology and urology · 2026Article
- KangDuoTranslational andrology and urology · 2026Article
- Prospective single-arm study of gastric surgery in experimental animals assisted by Kangduo surgical robot.International journal of surgery (London, England) · 2026Article
- Is Kangduo robotic distal pancreatectomy more economically efficient and effective in postoperative outcomes compared to laparoscopic surgery? A propensity-matched analysis.Journal of robotic surgery · 2025Article
- Beyond Da Vinci: Comparative Review of Next-Generation Robotic Platforms in Urologic Surgery.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In urological surgery, the Da Vinci Xi robotic system has many advantages, but it also has limitations such as high equipment costs and the need for professional training. Kangduo is a laparoscopic surgical robot developed in China, and SR2000 is its newly approved four-arm laparoscopic surgical robot. This study compares the short-term outcomes of the two in radical cystectomy. Data from a centre-based randomised non-inferiority trial were used and patients between March 2023 and June 2024 were enrolled and randomised according to criteria. The primary outcome was surgical success, and secondary outcomes included intraoperative variables, surgical outcomes, pathological outcomes, and postoperative outcomes. A total of 34 patients, 16 in the KD group and 18 in the DV group, had no intermediate open or conventional laparoscopic surgery, and the surgical success rate was 100%, with no significant differences between the two groups in many aspects. The effectiveness and safety of the KangDuo SR2000 system were demonstrated. Experienced surgeons confirmed that performing radical cystectomy using the KangDuo SR2000 system yielded results comparable to those achieved using the Da Vinci robotic system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.